CR10527A - Inibidores del canal de potasio de imidazol kv1.5 - Google Patents

Inibidores del canal de potasio de imidazol kv1.5

Info

Publication number
CR10527A
CR10527A CR10527A CR10527A CR10527A CR 10527 A CR10527 A CR 10527A CR 10527 A CR10527 A CR 10527A CR 10527 A CR10527 A CR 10527A CR 10527 A CR10527 A CR 10527A
Authority
CR
Costa Rica
Prior art keywords
inibidors
imidazol
potassium channel
compounds
present
Prior art date
Application number
CR10527A
Other languages
English (en)
Spanish (es)
Inventor
John Michael Janusz
Stephen Joseph Hodson
Gregory Kent Bosch
Ronald Eugene White
Benjamin E Blass
Christopher M Jackson
Neil T Fairweather
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR10527A publication Critical patent/CR10527A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CR10527A 2006-06-20 2008-12-18 Inibidores del canal de potasio de imidazol kv1.5 CR10527A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81509106P 2006-06-20 2006-06-20

Publications (1)

Publication Number Publication Date
CR10527A true CR10527A (es) 2009-02-19

Family

ID=38582320

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10527A CR10527A (es) 2006-06-20 2008-12-18 Inibidores del canal de potasio de imidazol kv1.5

Country Status (20)

Country Link
US (2) US7504517B2 (https=)
EP (1) EP2035392A1 (https=)
JP (1) JP2009541343A (https=)
KR (1) KR20090021223A (https=)
CN (1) CN101573341A (https=)
AR (1) AR061523A1 (https=)
AU (1) AU2007260985A1 (https=)
BR (1) BRPI0713320A2 (https=)
CA (1) CA2655574A1 (https=)
CL (1) CL2007001794A1 (https=)
CO (1) CO6150173A2 (https=)
CR (1) CR10527A (https=)
EC (1) ECSP088994A (https=)
MX (1) MX2008016399A (https=)
NO (1) NO20085252L (https=)
PE (1) PE20080942A1 (https=)
RU (1) RU2008150465A (https=)
TW (1) TW200815363A (https=)
WO (1) WO2007149874A1 (https=)
ZA (1) ZA200810763B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008150465A (ru) * 2006-06-20 2010-07-27 Вайет (Us) Ингибиторы калиевых каналов подтипа kv1.5
RU2373934C1 (ru) * 2008-03-19 2009-11-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
CN101544580B (zh) * 2009-04-28 2019-03-15 大连凯飞精细化工有限公司 R-alpha-氨基-4-甲氧基苯乙酰胺的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4099009A (en) * 1977-04-11 1978-07-04 Morton-Norwick Products, Inc. 1-(4-chlorophenyl)-3-(1-ureido)-2-imidazolidinone
SK94393A3 (en) 1992-09-11 1994-08-10 Thomae Gmbh Dr K Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those
DE4332168A1 (de) 1993-02-22 1995-03-23 Thomae Gmbh Dr K Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
HUP9901024A2 (hu) 1996-01-26 1999-09-28 Vertex Pharmaceuticals Incorporated Telített azolok oxoszármazékai, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
EP0891353A4 (en) 1996-04-03 2001-08-08 Merck & Co Inc FARNESYL PROTEIN TRANSFERASE INHIBITORS
US7129359B2 (en) 2002-07-09 2006-10-31 National Health Research Institutes Imidazolidinone compounds
US7544812B2 (en) 2001-11-30 2009-06-09 Eli Lilly And Company Peroxisome proliferator activated receptor agonists
US7189856B2 (en) 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands
AU2003302027A1 (en) 2002-11-21 2004-06-15 Vicore Pharma Ab New tricyclic angiotensin ii agonists
JP2004262903A (ja) 2003-03-04 2004-09-24 Japan Science & Technology Agency アジリジン類の製造方法
US7259174B2 (en) 2004-05-25 2007-08-21 National Health Research Institutes Imidazolidinone compounds
TW200624429A (en) 2004-09-07 2006-07-16 Glaxo Group Ltd Novel cysteine protease inhibitors
KR100677149B1 (ko) 2004-11-12 2007-02-02 삼성전자주식회사 잉크 조성물
RU2008150465A (ru) * 2006-06-20 2010-07-27 Вайет (Us) Ингибиторы калиевых каналов подтипа kv1.5

Also Published As

Publication number Publication date
NO20085252L (no) 2009-01-13
BRPI0713320A2 (pt) 2012-02-07
US7504517B2 (en) 2009-03-17
WO2007149874A8 (en) 2008-03-20
AU2007260985A1 (en) 2007-12-27
CO6150173A2 (es) 2010-04-20
KR20090021223A (ko) 2009-02-27
TW200815363A (en) 2008-04-01
JP2009541343A (ja) 2009-11-26
CA2655574A1 (en) 2007-12-27
EP2035392A1 (en) 2009-03-18
MX2008016399A (es) 2009-02-03
WO2007149874A1 (en) 2007-12-27
CL2007001794A1 (es) 2008-01-18
US20090069342A1 (en) 2009-03-12
US20070299120A1 (en) 2007-12-27
AR061523A1 (es) 2008-09-03
CN101573341A (zh) 2009-11-04
ECSP088994A (es) 2009-01-30
PE20080942A1 (es) 2008-09-03
ZA200810763B (en) 2009-09-30
US7803827B2 (en) 2010-09-28
RU2008150465A (ru) 2010-07-27

Similar Documents

Publication Publication Date Title
UY28290A1 (es) Compuestos farmacéuticos novedosos
UY28625A1 (es) Nuevos compuestos farmacéuticos
HN2007000437A (es) Compuestos de pirazolina y su uso y composiciones farmaceuticas
CR11355A (es) Derivados de quinazolinona 6-, 7-, u 8-sustituidos y composiciones que los comprenden
CR9898A (es) Derivados de prolinamida como moduladores del canal de sodio
ECSP12011625A (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
PA8796901A1 (es) Inhibidores de la interaccion entre mdm2 y p53
ECSP10010013A (es) Nuevos fungicidas
HN2009001282A (es) Compuestos y composiciones como inhibidores de proteasa activadora de canal
PA8625201A1 (es) Composiciones de peróxido estabilizadas
PA8667201A1 (es) Nuevos compuestos farmaceuticos
EP4110478C0 (en) DISINFECTANT COMPOSITIONS
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
EP4121059A4 (en) NLRP3 MODULATORS
CL2021002108A1 (es) Desinfectante endoscopico mejorado
GT200500357A (es) Indazoles substituidos, composicones que los comprenden, procedimiento de su preparacion y utilizacion
CR10527A (es) Inibidores del canal de potasio de imidazol kv1.5
DK1608344T3 (da) Orale cladribin-formuleringer
PA8606601A1 (es) Sistemas emulsionantes que contienen derivados de azetidina
NO20063293L (no) Farmasoytiske forbindelser
JP1749765S (ja) プランター
IL310652A (en) Formulations of radiprodil
EP4188088A4 (en) Formulations
EP4175676A4 (en) MUCO-PENETRATING FORMULATIONS
EA200900137A1 (ru) Комбинация ингибитора if-каналов синусного узла и бета-блокатора

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)